"Propofol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
| Descriptor ID |
D015742
|
| MeSH Number(s) |
D02.455.426.559.389.657.773
|
| Concept/Terms |
Propofol- Propofol
- 2,6-Diisopropylphenol
- 2,6 Diisopropylphenol
- 2,6-Bis(1-methylethyl)phenol
- Disoprofol
ICI-35,868- ICI-35,868
- ICI 35,868
- ICI35,868
- ICI-35868
- ICI 35868
- ICI35868
|
Below are MeSH descriptors whose meaning is more general than "Propofol".
Below are MeSH descriptors whose meaning is more specific than "Propofol".
This graph shows the total number of publications written about "Propofol" by people in this website by year, and whether "Propofol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 |
| 1997 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 4 | 0 | 4 |
| 2002 | 1 | 2 | 3 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 2 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 2 | 4 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 4 | 0 | 4 |
| 2014 | 3 | 0 | 3 |
| 2015 | 1 | 0 | 1 |
| 2017 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 2 | 0 | 2 |
| 2022 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Propofol" by people in Profiles.
-
INhaled Sedation versus Propofol in REspiratory failure in the Intensive Care Unit (INSPiRE-ICU1): protocol for a randomised, controlled trial. BMJ Open. 2024 Oct 26; 14(10):e086946.
-
Propofol selectively modulates functional connectivity signatures of sustained attention during rest and narrative listening. Cereb Cortex. 2022 11 21; 32(23):5362-5375.
-
Propofol Versus Remifentanil Sedation for Transcatheter Aortic Valve Replacement: A Single Academic Center Experience. J Cardiothorac Vasc Anesth. 2022 01; 36(1):103-108.
-
Nurse-Administered Propofol Continuous Infusion Sedation: A New Paradigm for Gastrointestinal Procedural Sedation. Am J Gastroenterol. 2021 04; 116(4):710-716.
-
Nurse-Administered Propofol Continuous Infusion Sedation for Gastrointestinal Endoscopy in Patients Who Are Difficult to Sedate. Clin Gastroenterol Hepatol. 2021 01; 19(1):180-188.
-
Reply to letter "A fatal adverse event upon adenotonsillectomy in a child. Are Brugada syndrome and propofol real accomplices?" Cardiol Young. 2020 09; 30(9):1370-1371.
-
Post-operative Brugada electrocardiographic pattern, polymorphic ventricular tachycardia, and sudden death in a child after administration of propofol anaesthesia. Cardiol Young. 2020 May; 30(5):724-727.
-
Computer-Assisted Propofol Sedation for Esophagogastroduodenoscopy Is Effective, Efficient, and Safe. Dig Dis Sci. 2019 12; 64(12):3549-3556.
-
Optimizing intraoperative administration of propofol, remifentanil, and fentanyl through pharmacokinetic and pharmacodynamic simulations to increase the postoperative duration of analgesia. J Clin Monit Comput. 2019 Dec; 33(6):959-971.
-
Propofol Sedation Exacerbates Kidney Pathology and Dissemination of Bacteria during Staphylococcus aureus Bloodstream Infections. Infect Immun. 2017 07; 85(7).